Email this article PROGNOSTIC FACTORS OF TUMORAL PROCESS IN PATIENTS WITH DISSEMINATED COLORECTAL CANCER
- Authors: Zorina Y.Y.1, Orlova R.V.2
-
Affiliations:
- City Clinical Oncology Dispensary, Saint-Petersburg
- Medical Faculty, Saint-Petersburg State University
- Issue: Vol 3, No 2 (2014)
- Pages: 33-40
- Section: ORIGINAL REPORTS
- Published: 26.02.2015
- URL: https://onco-surgery.info/jour/article/view/36
- DOI: https://doi.org/10.17650/2220-3478-2014-0-2-33-40
- ID: 36
Cite item
Full Text
Abstract
New prognostic factors for disseminated colorectal cancer (dCRC) are being investigated in this article.
Subjects and methods. In this study we have analyzed three clinical groups. First group – 60 patients with dCRC had not specifical therapy. Second group – 200 patients had specifical therapy, but without identification of prognostic and predictive markers. And third group – 93 patients had individual therapy which was based on prognostic and predictive markers of each patient.
Results. Definition of prognostic factors (TS, TP, DPD, Ercc-1, СОХ-2, MSI, KRAS) in patients with dCRC allowed to prescribe optimal specific therapy and improve results of treatment.
Conclusion. Investigation of prognostic markers allowed to differentiate prognostic groups among dCRC patients. Investigation of prognostic factors in patients with intermediate prognosis allows to improve treatment outcome and improve number of liver surgery.
About the authors
Ye. Yu. Zorina
City Clinical Oncology Dispensary, Saint-Petersburg
Author for correspondence.
Email: bryk74@mail.ru
Russian Federation
R. V. Orlova
Medical Faculty, Saint-Petersburg State University
Email: bryk74@mail.ru
Russian Federation
References
Supplementary files
